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Abstract 
Purpose: To examine the effects of reduced CHO but high post-exercise fat availability on cell 
signalling and expression of genes with putative roles in regulation of mitochondrial biogenesis, 
lipid metabolism and muscle protein synthesis (MPS). Methods: Ten males completed a twice 
per day exercise model (3.5 h between sessions) comprising morning high-intensity interval 
(HIT) (8 x 5-min at 85% VO2peak) and afternoon steady-state (SS) running (60 min at 70% 
VO2peak).  In a repeated measures design, runners exercised under different isoenergetic dietary 
conditions consisting of high CHO (HCHO: 10 CHO, 2.5 Protein and 0.8 Fat g.kg
-1
 per whole 
trial period) or reduced CHO but high fat availability in the post-exercise recovery periods 
(HFAT: 2.5 CHO, 2.5 Protein and 3.5 Fat g.kg
-1
 per whole trial period).  Results: Muscle 
glycogen was lower (P<0.05) at 3 (251 vs 301 mmol.kg
-1
dw) and 15 h (182 vs 312 mmol.kg
-
1
dw) post-SS exercise in HFAT compared to HCHO.  AMPK-α2 activity was not increased post-
SS in either condition (P=0.41) though comparable increases (all P<0.05) in PGC-1α, p53, CS, 
Tfam, PPAR and ERRα mRNA were observed in HCHO and HFAT.  In contrast, PDK4 
(P=0.003), CD36 (P=0.05) and CPT1 (P=0.03) mRNA were greater in HFAT in the recovery 
period from SS exercise compared with HCHO. p70S6K activity was higher (P=0.08) at 3 h 
post-SS exercise in HCHO versus HFAT (72.7 ± 51.9 vs 44.7 ± 27 fmol.min
-1 
mg
-1
). 
Conclusion: Post-exercise high fat feeding does not augment mRNA expression of genes 
associated with regulatory roles in mitochondrial biogenesis though it does increase lipid gene 
expression. However, post-exercise p70S6K1 activity is reduced under conditions of high fat 
feeding thus potentially impairing skeletal muscle remodelling processes.   
Keywords: AMPK-α2, PGC-1α, p53, glycogen, mitochondrial biogenesis 
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Introduction 
Traditional nutritional strategies for endurance athletes have largely focused on ensuring high 
CHO availability before, during and after each training session (2).  However, accumulating data 
from our laboratory (7, 29) and others (12, 16, 17, 23, 39) have demonstrated a potent effect of 
CHO restriction (the so-called “train-low” paradigm) in augmenting the adaptive responses 
inherent to endurance training. Indeed, reduced CHO availability before (33) during (1) and after 
(32) training sessions augments the acute cell signalling pathways and downstream gene 
expression responses associated with regulating training adaptation. Accordingly, reduced CHO 
availability during short-term periods of endurance training augments markers of mitochondrial 
biogenesis (16, 39, 29), increases both whole body (39) and intramuscular lipid metabolism (17) 
and also improves exercise capacity and performance (16, 24). In the context of nutrient-gene 
interactions, it is therefore apparent that the acute molecular regulation of cell signalling 
processes provides a theoretical basis for understanding the molecular mechanisms underpinning 
chronic training adaptations.  
In addition to manipulation of CHO availability, many investigators have also demonstrated a 
modulatory role of high fat availability in augmenting components of training adaptation (10. For 
example, the acute elevation in circulating free fatty acid (FFA) availability during exercise 
regulates key cell signalling kinases and transcription factors that modulate the expression of 
genes regulating both lipid and CHO metabolism (31, 40).  Additionally, 5-15 days of high fat 
feeding increases resting intramuscular triglyceride stores (38), hormone sensitive lipase (38), 
carnitine palmitoyltransferase (CPT1) (15), adenosine monophosphate activated protein kinase 
(AMPK)-α2 activity (38) and protein content of fatty acid translocase (FAT/CD36) (11).  Such 
adaptations undoubtedly contribute to the enhanced rates of lipid oxidation observed during 
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exercise following “fat adaptation” protocols (10). Taken together, these data suggest carefully 
chosen periods of reduced CHO but concomitant high fat availability may therefore represent a 
strategic approach for which to maximise both training-induced skeletal muscle mitochondrial 
biogenesis and the enhanced capacity to utilise lipid sources as fuels during exercise. 
However, such a feeding strategy is not without potential limitations especially if performed on 
consecutive days.  Indeed, reduced CHO availability impairs acute training intensity (17, 39) and 
five days of high fat feeding reduces pyruvate dehydrogenase (PDH) activity (35), thus 
potentially leading to a de-training effect, reduced capacity to oxidise CHO and ultimately, 
impaired competition performance (17, 39).  Moreover, although many endurance training-
induced skeletal muscle adaptations are regulated at a transcriptional level, the turnover of 
myofibrillar (i.e. contractile) proteins are largely regulated through the translational machinery 
and the mechanistic target of rapamycin complex (mTOR) and ribosomal protein S6 kinase 1 
(p70S6K) signalling axis (28).  In this regard, recent data suggests high circulating FFA 
availability impairs muscle protein synthesis despite the intake of high quality protein, albeit 
examined via lipid and heparin fusion and euglycemic hyperinsulemic clamp conditions (36).   
With this in mind, the aim of the present study was to examine the effects of reduced CHO but 
high post-exercise fat availability on the activation of key cell signalling kinases and expression 
of genes with putative roles in the regulation of mitochondrial biogenesis, lipid metabolism and 
muscle protein synthesis.  In accordance with the original train-low investigations (16, 17, 29, 
39), we employed a twice per day exercise model whereby trained male runners completed a 
morning high-intensity interval training session followed by an afternoon training session 
consisting of steady-state running.  Runners completed the exercise protocols under two different 
dietary conditions (both energy and protein matched) consisting of high CHO availability 
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(HCHO) in the recovery period after both training sessions (i.e. best practice nutrition) or 
alternatively, reduced CHO but high fat availability in the post-exercise recovery periods 
(HFAT).  We specifically hypothesised that our high fat feeding protocol would enhance cell 
signalling and the expression of those genes with putative roles in the regulation of 
mitochondrial biogenesis and lipid metabolism but would also impair the activity of muscle 
protein synthesis related signalling. 
 
Methods 
Subjects: Ten trained male runners volunteered to participate in the study (mean ± SD: age, 24 ± 
1.5 years; body mass, 75.9 ± 6 kg; height, 177.3 ± 7.2 cm; VO2peak, 60 ± 3.6 ml·kg
-1
·min
-1
). All 
subjects gave written informed consent prior to participation after all experimental procedures 
and potential risks had been fully explained. None of the subjects had any history of 
musculoskeletal or neurological disease, nor were they under any pharmacological treatment 
over the course of the testing period. Subjects were instructed to refrain from any strenuous 
physical activity, alcohol and caffeine consumption in the 48h prior to each experimental trial. 
The study was approved by the ethics committee of Liverpool John Moores University.  
Design: In a repeated measures, randomised, cross-over design separated by 7 days, subjects 
completed a twice per day exercise model under two different dietary conditions (both energy 
and protein matched) consisting of high CHO availability (HCHO) in the recovery period after 
both training sessions (i.e. best practice nutrition) or alternatively, reduced CHO but high fat 
availability in the post-exercise recovery periods (HFAT).  The twice per day exercise model 
comprised a morning (9-10 am) high-intensity interval (HIT) training session (8 x 5-min at 85% 
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VO2peak) followed by an afternoon (130-230 pm) training session consisting of steady-state (SS) 
running (60 min at 70% VO2peak).  To promote training compliance during the HIT protocol in 
both the HCHO and HFAT trials, subjects adhered to a standardised high CHO breakfast prior to 
this session. However, during the 3.5 h recovery between the HIT and SS session and in the 
recovery period upon completion of the SS exercise protocol until the subsequent morning, 
subjects adhered to either a HCHO or HFAT feeding protocol. Muscle biopsies were obtained 
from the vastus lateralis muscle immediately pre-HIT, immediately post-SS and at 3 h and 15 h 
post-SS. An overview of the experimental design and nutritional protocols are shown in Figure 1. 
Preliminary testing: At least 7-10 days prior to the first main experimental trial, subjects 
performed a maximal incremental running test to volitional fatigue on a motorised treadmill 
(h/p/Cosmos, Nussdorf-Traunstein, Germany) in order to determine maximal oxygen uptake. 
Following a 10 minute warm up at a self-selected treadmill speed the maximal incremental test 
commenced, beginning with a 2-min stage at a treadmill speed of 10km/h. Running speed was 
then increased by 2km/h every 2-min until a speed of 16km/h was reached, after which the 
treadmill inclined by 2% every 2-min until volitional exhaustion. VO2peak was defined as the 
highest VO2 value obtained during any 10-s period and was stated as being achieved by two of 
the following criteria: 1) heart rate was within 10 beats.min
-1
 (bpm) of age-predicted maximum, 
2) respiratory exchange ratio > 1.1, and 3) plateau of oxygen consumption despite increased 
workload.  On their second visit to the laboratory (approx. 3 days later), subjects completed a 
running economy test in order to determine their individual running speeds for subsequent 
experimental trials.  Following a warm up, the test began with a 5-min stage at a treadmill speed 
of 8km/h with 1% incline and speed was then increased by 1km/h every 5-mins thereafter .  The 
test was stopped when >90% of the previously determined VO2peak was reached. These 
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measurements were recorded via breath-by-breath gas measurements obtained continuously 
throughout both tests using a CPX Ultima series online gas analysis system (Medgraphics, 
Minnesota, US). The test-retest reliability of this system in our laboratory when quantified using 
95% limits of agreement is 0.29 ± 2.4 ml.kg
-1
 min
-1 
 (data were compiled from comparison of the 
oxygen uptake during the HIT protocols in the HCHO and HFAT trials undertaken in the present 
study). Heart rate (Polar, Kempele, Finland) was also recorded continuously during exercise.   
Experimental protocols: 
HIT protocol: In the 24-h preceding each main experimental trial, subjects consumed a 
standardised high CHO diet in accordance with typical nutritional recommendations (8 g.kg
-1
 
CHO, 2 g.kg
-1
 protein, and 1 g.kg
-1
 fat). On the morning of each experimental trial, subjects 
reported to the laboratory at ~7 am where they were given a standardised high-CHO breakfast (2 
g.kg
-1
 CHO, 0.3 g.kg
-1
 protein, and 0.1 g.kg
-1
 fat). At 2-h post-prandial, a venous blood sample 
was then collected from an antecubital vein in the anterior crease of the forearm and a muscle 
biopsy sample taken from the vastus lateralis muscle.  Subjects were then fitted with a heart rate 
monitor and nude body mass (SECA, Hamburg, Germany) was recorded before commencing the 
high intensity interval running (HIT) protocol which lasted ~1-h.     The HIT protocol consisted 
of 8 x 5-min bouts running at a velocity corresponding to 85% VO2peak interspersed with 1-min 
of recovery at walking pace.  The intermittent protocol started and finished with a 10-min warm 
up and cool down at a velocity corresponding to 50% VO2peak, and a further venous blood sample 
was obtained immediately upon completion of the protocol. Water was given ad libitum 
throughout the duration of exercise with the pattern of intake recorded and replicated for the 
subsequent experimental trial. Heart rate was measured continuously during exercise (Polar, 
Kempele, Finland) and ratings of perceived exertion (RPE, 9) were obtained upon completion of 
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each HIT bout.  In order to determine substrate utilisation during exercise (20), expired gas was 
collected via a mouthpiece connected to an online gas analysis system (CPX Ultima, 
Medgraphics, Minnesota, US) for the final 2-mins of each 5-min interval.   
SS protocol:  During the 3.5 h recovery period between the HIT and SS protocols, subjects 
consumed either the HCHO (2.5 g.kg
-1
 CHO, 1 g.kg
-1
 Protein, 0.3 g.kg
-1
 Fat) or HFAT (0 g.kg
-1
 
CHO, 1 g.kg
-1
 Protein, 1 g.kg
-1
 Fat) feeding protocols (the pattern and frequency of feeding is 
shown in Figure 1).  Following the recovery period, another venous blood sample was obtained 
immediately prior to commencing the afternoon SS exercise protocol. After a 5-min warm up at 
a self-selected treadmill speed, subjects subsequently commenced the 60-min steady state 
running (SS) protocol at a velocity corresponding to 70% VO2peak.  During exercise, subjects also 
consumed 60 g.h
-1
 of CHO (SiS GO Istonic Gels, Science in Sport, Blackburn, UK) in HCHO 
whereas no form of energy was consumed in the HFAT trial. Water was given ad libitum 
throughout the duration of exercise with the pattern of intake recorded and replicated for the 
subsequent experimental trial. Expired gases were also collected for 5-mins at 15-min intervals 
throughout the exercise trial (CPX Ultima, Medgraphics, Minnesota, US) and substrate 
utilisation again determined according to Jeukendrup and Wallis (20). Heart rate was measured 
continuously during exercise (Polar, Kempele, Finland) and ratings of perceived exertion (RPE, 
9) were obtained every 15 minutes during exercise. Upon completion of the SS protocol until 
sleep, subjects consumed either the HCHO (3.6 g.kg
-1
 CHO, 1.5 g.kg
-1
 Protein, 0.4 g.kg
-1
 Fat) or 
HFAT (0.2 g.kg
-1
 CHO, 1.5 g.kg
-1
 Protein, 2.3 g.kg
-1
 Fat) feeding protocols where the pattern 
and frequency of feeding is shown in Figure 1. Vastus lateralis muscle biopsies and venous blood 
samples were also collected immediately post- and at 3 h and 15 h post completion (i.e. ~8 am 
and in a fasted state) of the SS exercise protocol.  The total energy intake across the whole trial 
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period (i.e 7 am – 9 pm) in HCHO was: ~10 g.kg-1 CHO, ~2.5 g.kg-1 Protein and ~0.8 g.kg-1 Fat,  
and in HFAT was: ~2.5 g.kg
-1
 CHO, ~2.5 g.kg
-1
 Protein and ~3.5 g.kg
-1
 Fat, where both trials 
were matched for total energy intake.  
Blood sampling and analysis: Venous blood samples were collected into vacutainers containing 
EDTA or lithium heparin and stored on ice until centrifugation at 1500g for 15-mins at 4ºC.  
Following centrifugation, aliquots of plasma were stored in a freezer at -80ºC for subsequent 
analysis.  Samples were later analysed for plasma glucose, lactate, non-esterified fatty acids 
(NEFA), glycerol, and β-hydroxybutyrate using commercially available enzymatic 
spectrophotometric assays (RX Daytona Analyser, Randox, Co. Antrim, UK) as per the 
manufacturers‟ instructions.       
Muscle biopsies: Muscle biopsy samples (~50 mg) were obtained from the lateral portion of the 
vastus lateralis muscle using a Bard Monopty Disposable Core Biopsy Instrument 12 gauge x 10 
cm length, (Bard Biopsy Systems, Tempe, AZ, USA).  Samples were obtained from separate 
incision sites 2-3 cm apart under local anaesthesia (0.5% Marcaine) and immediately frozen in 
liquid nitrogen and stored at -80ºC for later analysis.     
Analysis of muscle glycogen: Muscle glycogen concentration was determined according to the 
methods described by van Loon et al (37). Approximately 3-5 mg of freeze dried muscle was 
powdered and all visible blood and connective tissue removed.  The freeze dried sample was 
then hydrolysed by incubation in 500 µl of 1M HCl for 3 hours at 100
◦
C.  After cooling to room 
temperature for ~20-min, samples were neutralized by the addition of 250µl 0.12 mol.L
-1
 
Tris/2.1 mol.L
-1
 KOH saturated with KCl.  Following centrifugation at 1500 RCF for 10-mins at 
4ºC, 200 µl of the supernatant was analysed in duplicate for glucose concentration according to 
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the hexokinase method using a commercially available kit (GLUC-HK, Randox Laboratories, 
Antrim, UK). Glycogen concentration is expressed as mmol.kg
-1
 dry weight and intra-assay 
coefficients of variation were <5%.  
RNA isolation and analysis: Muscle biopsy samples (~20 mg) were homogenized in 1ml TRIzol 
reagent (Thermo Fisher Scientific, UK) and total RNA isolated according to manufacturer‟s 
guidelines. Concentrations and purity of RNA were assessed by UV spectroscopy at ODs of 260 
and 280 nm using a Nanodrop 3000 (Fisher, Rosklide, Denmark). 70 ng RNA was then used for 
each PCR reaction.  Samples were ran in duplicate.  
Primers: Identification of primer sequences was enabled by Gene 
(NCBI, http://www.ncbi.nlm.nih.gov.gene) and primers designed using Primer-BLAST 
(NCBI, http://www.ncbi.nlm.nih.gov/tools/primer-blast). Specificity was ensured using sequence 
homology searches so the primers only matched the experimental gene with no unintended 
targets identified for primer sequences.  In order to prevent amplification of gDNA, primers were 
ideally designed to yield products spanning exon-exon boundaries. 3 or more GC bases in the 
last 5 bases at the 3 end, and secondary structure interactions (hairpins, self-dimer and cross 
dimer) within the primers were avoided so there would be no non-specific amplification. All 
primers were between 16 and 25bp, and amplified a product between 141 – 244bp.  All primers 
were purchased from Sigma (Suffolk, UK) and sequences for each gene are shown in 
parentheses: peroxisome proliferator-activated γ receptor coactivator (PGC-1) (fwd: 
TGCTAAACGACTCCGAGAA, rev: TGCAAAGTTCCCTCTCTGCT), tumour suppressor protein 
(p53) (fwd: ACCTATGGAAACTACTTCCTGAAA, rev: CTGGCATTCTGGGAGCTTCA), 
mitochondrial transcription factor A (Tfam) (fwd: TGGCAAGTTGTCCAAAGAAACCTGT, rev: 
GTTCCCTCCAACGCTGGGCA), citrate synthase (CS) (fwd: CCTGCCTAATGACCCCATGTT, rev: 
CC
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CATAATACTGGAGCAGCACCCC), estrogen related receptor (ERR)-α (fwd: 
TGCCAATTCAGACTCTGTGC, rev: CCAGCTTCACCCCATAGAAA), peroxisome proliferator-
activated receptor (PPAR) (fwd: ATGGAGCAGCCACAGGAGGAAGCC, rev: 
GCATGAGGCCCCGTCACAGC), pyruvate dehydrogenase kinase, isozyme 4 (PDK4) (fwd:  
TGGTCCAAGATGCCTTTGAGT, rev: GTTGCCCGCATTGCATTCTT),  Glucose transporter type 4 
(GLUT4) (fwd: TCTCCAACTGGACGAGCAAC,  rev: CAGCAGGAGGACCGCAAATA)   carnitine 
palmitoyltransferase (CPT1) (fwd: GACAATACCTCGGAGCCTCA, rev: 
AATAGGCCTGACGACACCTG), fatty acid translocase (FAT/CD36) (fwd: 
AGGACTTTCCTGCAGAATACCA, rev: ACAAGCTCTGGTTCTTATTCACA), and GAPDH (fwd: 
AAGACCTTGGGCTGGGACTG, rev: TGGCTCGGCTGGCGAC). 
Reverse transcriptase quantitative Real-Time Polymerase Chain Reaction (rt-qRT-PCR): rt-
qRT-PCR amplifications were performed using a QuantiFast
TM
 SYBR
®
 Green RT-PCR one step 
kit on a Rotogene 3000Q (Qiagen, Crawley, UK) supported by Rotogene software (Hercules, 
CA, USA). The following rt-qTR-PCR cycling parameters were used: hold 50°C for 10 min 
(reverse transcription/cDNA synthesis), initial denaturation and transcriptase inactivation at 95°C 
for 5 min, followed by PCR steps: 40 cycles of denaturation at 95°C for 10s, and 
annealing/extension at 60°C for 30s. Upon completion, dissociation/melting curve analysis were 
performed to reveal and exclude non-specific amplification or primer-dimer issues (all melt 
analysis presented single reproducible peaks for each target gene suggesting amplification of a 
single product). Changes in mRNA content were calculated using the comparative Ct (
ΔΔ
Ct) 
equation (34) where relative gene expression was calculated as 2
-ΔΔct
 and where represents the 
threshold cycle. GAPDH was used as a reference gene and did not change significantly between 
groups or time points studied (Ct = 24.2±1), therefore a pooled reference gene Ct was used in the 
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relative gene expression equation above.  Furthermore, to enable calculation of expression values 
immediately post and 3-h post exercise, the calibrator condition in the delta delta Ct equation was 
assigned to the pre-exercise condition.        
[γ-32P] ATP Kinase Assay: Approximately 10-20 mg of muscle tissue was used for the 
measurement of p70S6K1 and AMPKα2 activity as previously described (27). 
Statistical analysis: All data were analysed using Statistical Package for the Social Scientist 
(SPSS version 21, IBM, USA). Metabolic responses (i.e. blood metabolites, muscle glycogen, 
kinase activity, mRNA data), physiological and perceptual responses (i.e. HR, RPE, and 
oxidation rates) were analysed using a two-way repeated-measures general linear model, where 
the within factors were time and condition (HCHO vs HFAT). Post hoc LSD tests were used 
where significant main effects and interactions were observed in order to locate specific 
differences between time points and conditions. All data in text, figures and tables are presented 
as mean ± SD, with P values ≤0.05 indicating statistical significance.  
 
Results 
Physiological responses and substrate utilisation during exercise.   
Comparisons of subjects‟ heart rate, RPE and substrate oxidation during the HIT and SS 
protocols are displayed in Table 1 and 2, respectively.  Heart rate, RPE and lipid oxidation (all 
P<0.01) all displayed progressive increases during both HIT (see Table 1) and SS exercise (see 
Table 2) whereas CHO oxidation displayed a progressive decrease (P<0.01) during both exercise 
protocols. In accordance with identical pre-exercise feeding in HIT, no significant differences 
were apparent in any of the aforementioned variables between HCHO and HFAT (P=0.06, 0.19, 
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0.52 and 0.56, respectively). In contrast, however, during the SS exercise protocol CHO 
oxidation was significantly greater in HCHO compared to HFAT (P<0.001) whereas fat 
oxidation was significantly greater during HFAT compared to HCHO (P < 0.001). 
 
Plasma metabolite responses: Plasma glucose, lactate, NEFA, glycerol and β-hydroxybutyrate 
all displayed significant changes (all P<0.01) over the sampling period (see Table 3).  However, 
in accordance with the provision of post-exercise CHO feeding in the HCHO trial, plasma 
glucose was significantly higher compared with HFAT (P<0.01) whereas post-exercise high fat 
feeding in HFAT induced significantly greater plasma NEFA, glycerol and β-OHB (all P<0.01) 
in HFAT compared with the HCHO trial. 
Muscle glycogen and exercise induced cell signalling:  Exercise induced significant decreases 
(P<0.01) in muscle glycogen immediately post-SS though no differences were apparent between 
HCHO and HFAT at this time-point (see Figure 2A). However, in accordance with the provision 
of CHO after the SS exercise protocol in HCHO, muscle glycogen re-synthesis was observed 
such that significant differences between HCHO and HFAT (P=0.01) were observed at 3 h and 
15 h post-SS exercise.  Neither exercise (P =0.407) nor dietary condition (P = 0.124) affected 
AMPK-α2 activity at any time-point studied (see Figure 2B).  In contrast, p70S6K1 activity was 
significantly increased 3 h post-SS exercise (30-mins post-feeding) (P<0.01), although this 
increase was supressed (P=0.08) in HFAT (see Figure 2C). Furthermore, p70S6K1 activity was 
significantly reduced at 15 h post-SS exercise when participants were fasted compared with pre-
HIT when they were high CHO and protein fed (P<0.01). 
AC
CE
PT
ED
Copyright © 2016 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
 
Gene expression: Exercise increased the expression of PGC-1α (P<0.001), p53 (P=0.032), CS 
(P=0.05), Tfam (P=0.05), PPAR (P<0.01) and ERRα (P=0.01) however, there were no 
differences (all P>0.05) between HFAT and HCHO trials (see Figure 3A-F).  In contrast, the 
exercise-induced increase (P=0.001) in PDK4 mRNA was greater in HFAT versus HCHO 
(P=0.003). Similarly, mRNA expression of CD36 (P=0.05) and CPT1 (P=0.02) was significantly 
greater in HFAT in recovery from the SS exercise protocol (see Figure 3). In contrast, neither 
exercise (P=0.12) nor diet (P=0.31) significantly affected GLUT expression (see Figure 3). 
Discussion 
The aim of the present study was to examine the effects of reduced CHO but high post-exercise 
fat availability on the activation of key cell signalling kinases and expression of genes with 
putative roles in the regulation of mitochondrial biogenesis, lipid metabolism and muscle protein 
synthesis.  When compared with high CHO availability, we observed that post-exercise high fat 
feeding had no modulatory affect on AMPK-α2 activity or the expression of those regulatory 
genes associated with mitochondrial biogenesis.  Furthermore, although post-exercise high fat 
feeding augmented the expression of genes involved in lipid transport (i.e. FAT/CD36) and 
oxidation (i.e. CPT1), we also observed suppression of p70S6K1 activity despite sufficient post-
exercise protein intake.  This latter finding suggests that post-exercise high fat feeding may 
impair the regulation of muscle protein synthesis and skeletal muscle remodelling processes, 
thereby potentially causing maladaptive responses for training adaptation if performed long-
term.  
In accordance with the original train-low investigations examining cycling or knee extensor 
exercise (16, 17, 29, 39), we also employed a twice per day protocol, albeit consisting of 
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morning HIT and afternoon SS running exercise protocol.  This model is practically relevant 
given that many elite endurance athletes (including runners) train multiple times per day with 
limited recovery time between training sessions (14).  Given that reduced CHO availability 
impairs high-intensity training capacity (17, 39), we also chose to schedule the HIT session in 
the morning period after a standardised high CHO breakfast.  As expected, no differences in 
cardiovascular strain, ratings of perceived exertion, substrate utilisation and plasma metabolite 
responses were observed between the HCHO and HFAT trials during the HIT session (see Table 
1 and 3).  Following completion of the HIT protocol, subjects then adhered to a HCHO or HFAT 
feeding protocol in the 3.5 h prior to commencing the afternoon SS exercise. Given that 
exogenous CHO feeding during exercise reduces oxidative adaptations even in the presence of 
reduced pre-exercise muscle glycogen (29), we also chose to feed exogenous CHO (at a rate of 
60 g/h) during the afternoon SS protocol during the HCHO trial.  Although we did not directly 
quantify muscle glycogen immediately prior to SS exercise, plasma metabolite and substrate 
utilisation during SS exercise were clearly suggestive of differences in both endogenous and 
exogenous CHO availability between the HCHO and HFAT trials.  Indeed, plasma NEFA, 
glycerol, β-OHB and whole body lipid oxidation were all greater during SS exercise undertaken 
in the HFAT trial compared with the HCHO trial (see Table 2 and 3).  On the basis of 
comparable muscle glycogen data post-SS exercise (see Figure 2A) and greater whole body 
CHO oxidation during the HCHO trial (see Table 2), we also suggest that exercise-induced 
muscle glycogen utilisation was greater during the SS exercise protocol when completed in the 
HCHO conditions (7).    
Perhaps surprisingly, we observed that our SS exercise protocol did not increase AMPK-α2 
activity in either the HCHO or HFAT trial. However, there are likely a number of 
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physiologically valid reasons to explain the apparent lack of AMPK mediated signalling.  
Indeed, exercise-induced AMPK activation is known to be intensity dependent where >70% 
VO2max is likely required to induce metabolic perturbations sufficient to mediate a signalling 
response (13).  Furthermore, the AMPK response to exercise is attenuated with exercise training 
(8), an effect that is especially relevant for the present investigation given the trained status of 
our chosen population and the low plasma lactate observed (approximately 2 mmol.L
-1
) during 
SS exercise.  Reduced absolute muscle fibre recruitment from the vastus lateralis, when 
compared with other lower extremity muscles recruited during walking and running (19), or 
when exercising at similar relative intensities during cycling (4) and where AMPK activation is 
typically reported (22) could also contribute, in part, to the lack of AMPK signalling observed 
here.  Finally, although exercise-induced AMPK activity is also thought to be regulated, in part, 
via a glycogen binding domain on β-subunit of the AMPK heterotrimer (26), it is possible that 
our runners did not exceed a potential “muscle glycogen threshold” that is required to fully 
activate the AMPK complex during prolonged endurance exercise (30).  Indeed, previous data 
from our laboratory also using running exercise protocols (6,7) have typically only observed 
AMPK related signalling when post-exercise whole muscle homogenate glycogen is <200 
mmol.kg
-1 
dw.  Despite previous suggestions that train-low training sessions should be targeted 
to SS exercise protocols so as to not compromise training intensity (5), our data therefore suggest 
(at least for AMPK mediated signalling) that perhaps it is the actual completion of a high-
intensity stimulus per se (especially in trained athletes) that is really required to create a 
metabolic milieu that is conducive to augmentation of necessary signalling networks.   
In contrast to Yeo et al. (38), we also observed no modulatory effect of post-exercise high fat 
availability on resting AMPK-α2 activity.  Indeed, these authors observed that 5 days of a fat 
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loading protocol increased resting AMPK-α2 activity as well as the exercise-induced 
phosphorylation of ACC
Ser221
.  Such discrepancies between studies are likely due to the 
differences in duration of high fat feeding in that we adopted an acute high fat feeding protocol 
(<24 h) whereas the latter authors adopted a 5 day “fat adaptation” protocol that also increased 
resting intramuscular triglyceride (IMTG) stores. In this regard, it is noteworthy that the 
magnitude of change in resting AMPK-α2 activity was positively correlated with the elevations 
in IMTG storage (38).  
In contrast to our hypothesis, we also observed comparable 2-3 fold changes between trials in 
mRNA expression of those genes with key regulatory roles associated with mitochondrial 
biogenesis.  For example, the expression of PGC-1α, p53, Tfam, PPAR and ERRα mRNA were 
all elevated with similar magnitude and time-course in recovery from the SS protocol in both the 
HCHO and HFAT trials.  Such data conflict with previous observations from our laboratory (7) 
and others (32) where post-exercise CHO restriction (i.e. keeping muscle glycogen low) 
augments the expression of many of the aforementioned genes.  However, in our previous report 
we simultaneously adopted a CHO but calorie restriction feeding protocol whereas the present 
design incorporated a reduced CHO but isocaloric and protein matched feeding protocol in our 
HFAT trial.  Given the similarities in metabolic adaptation to both CHO and calorie restriction, 
such data raise the question as to whether the enhanced mitochondrial responses observed when 
“training low” are due to transient periods of CHO restriction, calorie restriction or indeed, a 
combination of both.  This point is especially relevant from an applied perspective given that 
many endurance athletes present daily with transient periods of both CHO and calorie restriction 
due to multiple training sessions per day as well as longer term periods of sub-optimal energy 
availability (14).  
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In agreement with multiple studies demonstrating a role of both acute elevations in FFA 
availability (7, 23) as well as high fat feeding protocols (11), we also observed that post-exercise 
expression of PDK4, FAT/CD36 and CPT1 mRNA expression were elevated in the HFAT trial 
versus the HCHO trial.  However, unlike Arkinstall et al. (4), we did not detect any suppressive 
effects of high fat availability on GLUT4 mRNA expression though a longer and more severe 
period of CHO restriction utilised by these investigators (i.e. 48 h of absolute CHO intake <1 
g/kg body mass resulting in muscle glycogen levels <150 mmol.kg
-1
 dw) may explain the 
discrepancy between studies. Nonetheless, the dietary protocol studied here clearly alters the 
expression of genes with potent regulatory roles in substrate utilisation and if performed long 
term, may increase the capacity to use lipids as a fuel but induce suppressive effects on CHO 
metabolism (through suppression of the PDH complex) thus potentially limiting high-intensity 
performance (35). Whilst we did not directly quantify the signalling mechanisms underpinning 
these responses (owing to a lack of a muscle tissue), we suggest both p38MAPK and PPAR 
mediated signalling are likely involved. Indeed, using a twice per day exercise model, Cochran et 
al. (12) also observed enhanced p38MAPK phosphorylation during the afternoon exercise 
protocol (despite similar pre-exercise muscle glycogen availability) that was associated with the 
enhanced circulating FFA availability during the afternoon exercise. Furthermore, 
pharmacological ablation of circulating FFA availability during exercise suppresses p38MAPK 
compared with control conditions (40).  Additionally, FFA mediated signalling can also directly 
mediate PPAR binding to the CPT1 promoter thereby modulating CPT1 expression (31). 
We also examined the effects of post-exercise fat feeding on the regulation of p70S6K activity, a 
key signalling kinase associated with regulating MPS.  In relation to the effects of endurance 
exercise per se, the majority of studies are typically limited to measures of phosphorylation 
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status with some studies reporting increases (25) and others, no change.  When examined 
quantitatively using the [γ-32P] ATP kinase assay, our data agree with previous observations from 
Apro et al. (3) who also reported no change but yet, conflict with recent data from our group 
where we observed an exercise-induced suppression of p70S6K activity (18). Nonetheless, the 
exhaustive (a fatiguing cycling HIT protocol) and muscle glycogen depleting (<100 mmol.kg
-1
 
dw) nature of the latter exercise protocol versus the moderate-intensity nature of the afternoon 
SS running protocol studied here, likely explains the discrepancy between studies.  
In relation to the effects of post-exercise feeding, we also provide novel data by demonstrating 
that post-exercise high fat feeding was associated with a suppression of p70S6K activity (albeit 
P=0.08) at 3 h post-completion of the SS exercise protocol when compared with the elevated 
response observed in HCHO  (when using both a mean difference and standard deviation of 
differences of 50 fmol.min
-1
.mg
-1
, we estimate a sample size of 12-13 would be required to 
achieve statistical significance with 90% power, as calculated using Minitab statistical software, 
version 17).  Although we did not measure circulating insulin levels in this study, it is of course 
possible that the suppressed p70S6K response observed here may be due to reduced upstream 
insulin mediated activation of protein kinase B (PKB). Indeed, we recently observed post-
exercise p70S6K activity to be suppressed in conditions of simultaneous carbohydrate and 
calorie restriction in a manner associated with reduced insulin and upstream signalling of PKB 
(18).  Alternatively, the suppression of p70S6K observed here may be mediated through direct 
effects of post-exercise high fat feeding that are independent of CHO availability, energy 
availability and insulin. Indeed, Stephens et al. (36) observed infusion of Intralipid and heparin 
to elevate circulating FFA concentrations attenuates MPS in human skeletal muscle in response 
to ingesting 21g amino acids under euglycemic hyperinsulemic clamp conditions.  Furthermore, 
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Kimball et al. (21) also reported that high fat feeding impairs MPS in rat liver in a manner 
associated with reduced p70S6K phosphorylation, an effect that may be induced through sestrin 
2 and sestrin 3 mediated impairment of mTORC signalling.  Clearly, further research is required 
to examine the effects of high fat feeding on direct measures (and associated regulatory sites) of 
MPS within the physiological context of the exercising human. 
In summary, we provide novel data by concluding that post-exercise high fat feeding has no 
modulatory affect on AMPK-α2 activity or the expression of those genes associated with 
regulatory roles in mitochondrial biogenesis.  Furthermore, although post-exercise high fat 
feeding augmented the expression of genes involved in lipid transport and oxidation, we also 
observed a suppression of p70S6K1 activity despite sufficient post-exercise protein intake.  This 
latter finding suggests that post-exercise high fat feeding may impair the regulation of muscle 
protein synthesis and post-exercise muscle remodelling, thereby potentially causing maladaptive 
responses for training adaptation if performed long-term. Future studies should now examine the 
functional relevance of the signalling responses observed here, not only in terms of acute muscle 
protein synthesis but also the chronic skeletal muscle and performance adaptations induced by 
long-term use of this feeding strategy. 
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FIGURE 1 - Overview of the experimental protocol employed in each trial. HIT = 8 x 5mins 
running at a workload equal to 85% VO2peak interspersed by 1min recovery. SS = 1-hour steady 
state running at a workload equal to 70% VO2peak.  
 
FIGURE 2 – (A) Skeletal muscle glycogen content, (B) AMPK-α2 and (C) p70S6K1 activity 
before HIT exercise and after the SS exercise protocol. # denotes significant difference from Pre-
HIT, P<0.05. * denotes significant difference between conditions, P<0.05.  $ denotes difference 
between conditions, P=0.08. 
 
FIGURE 3 – (A) PGC-1 α, (B) PPAR, (C) p53, (D) Tfam, (E) CS, (F) ERRα, (G) PDK4, (H) 
GLUT4, (I) CPT1 and (J) CD36 mRNA before HIT exercise and after the SS exercise protocol.  
# denotes significant difference from Pre-HIT, P<0.05. * denotes significant difference between 
conditions, P<0.05.   
 
TABLE 1 – Heart rate, RPE and substrate oxidation responses during the HIT protocol in both 
the HCHO and HFAT trials. * denotes significant difference from HIT-1, P<0.05.  
 
 
TABLE 2 – Heart rate, RPE and substrate oxidation during the SS protocol in both the HCHO 
and HFAT trials. * denotes significant difference from 15 min, P<0.05. # denotes significant 
difference between conditions, P<0.05.   
 
TABLE 3 – Plasma (A) glucose, (B) lactate, (C) NEFA, (D) glycerol and (E) β-OHB before and 
after the HIT and SS exercise protocols. # denotes significant difference from Pre-HIT, P<0.05. * 
denotes significant difference between conditions, P<0.05.   
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Figure 1 
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Figure 2 
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Figure 3 
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TABLE 1 – Heart rate, RPE and substrate oxidation responses during the HIT protocol in both 
the HCHO and HFAT trials. * denotes significant difference from HIT-1, P<0.05.  
 
  
 HIT (Bout number) 
1 2 3 4 5 6 7 8 
Heart rate 
(b.min
-1
) 
        
HCHO 177 ± 9 181 ± 9 184 ± 8 185 ± 6* 186 ± 6* 185 ± 5 185 ± 5* 186 ± 7* 
HFAT 173 ± 10 174 ± 8 180 ± 6 182 ± 7* 182 ± 7* 179 ± 6 182 ± 8* 184 ± 7* 
RPE          
HCHO 14 ± 1.4 15 ± 1.5* 16 ± 2.0* 17 ± 1.6* 18 ± 0.9* 18 ± 1.0* 19 ± 0.6* 19 ± 0.7* 
HFAT 14 ± 1.6 15 ± 1.8* 16 ± 1.9* 17 ± 1.1* 18 ± 1.2* 18 ± 1.0* 19 ± 0.9* 19 ± 1.03* 
CHOoxidation 
(g.min
-1
) 
        
HCHO 5.5 ±2.6 5.1 ± 1.4 4.9 ± 1.4 4.4 ± 1.4 3.9 ± 2.1* 3.7 ± 1.9* 3.5 ± 2.3* 3.8 ± 2.7* 
HFAT  5.5 ± 2.7 4.8 ± 1.8 4.5 ± 1.6 4.4 ± 1.5 4.1 ± 2.2* 3.6 ± 1.9* 3.6 ± 2.4* 3.7 ± 2.7* 
Fat oxidation 
(g.min
-1
) 
        
HCHO 0.00 ± 0.29 0.00 ± 1.2 0.00 ± 1.4 0.06 ± 1.8 0.25 ± 2.2* 0.3 ± 2.5* 0.38 ± 3.1* 0.31 ± 3.5* 
HFAT  0.00 ± 0.96 0.00 ± 1.1 0.03 ± 1.4 0.09 ± 1.8 0.19 ± 2.1* 0.3 ± 2.5* 0.37 ± 3.0* 0.34 ± 3.4* AC
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TABLE 2 – Heart rate, RPE and substrate oxidation during the SS protocol in both the HCHO 
and HFAT trials. * denotes significant difference from 15 min, P<0.05. # denotes significant 
difference between conditions, P<0.05.   
 
  
Time (mins) 
15 30 45 60 
Heart rate  
(b.min
-1
) 
    
HCHO 166 ± 12 169 ± 11 170 ± 12* 172 ± 12* 
HFAT 161 ± 11 165 ± 12 166 ± 10* 168 ± 10* 
RPE     
HCHO 13 ± 1.3 14 ± 1.5* 15 ± 1.8 15 ± 1.8* 
HFAT  13 ± 1.4 14 ± 1.8* 15 ± 2.1 16 ± 1.4* 
CHO oxidation 
(g.min
-1
) 
    
HCHO 3.4 ±0.8 3.1 ± 1.2*# 3.5 ± 0.9*# 3.3 ± 0.6*# 
HFAT  2.8 ±0.5 2.3 ± 0.4*# 2.1 ± 0.5*# 2.0 ± 0.6*# 
Fat oxidation  
(g.min
-1
) 
    
HCHO 0.00 ± 0.30 0.13 ± 0.30*# 0.26 ± 0.31*# 0.35 ± 0.31*# 
HFAT  0.32 ± 0.30 0.55 ± 0.20*# 0.65 ± 0.31*# 0.71 ± 0.40*# AC
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TABLE 3 – Plasma glucose, lactate, NEFA, Glycerol and β-OHB before and after the HIT and 
SS exercise protocols. # denotes significant difference from Pre-HIT, P<0.05. * denotes 
significant difference between conditions, P<0.05.   
 
 Pre HIT Post HIT Pre SS Post SS 3-h Post SS 15-h Post SS 
Glucose  
(mmol.L
-1
) 
      
HCHO 5.2 ± 0.863  7.6 ± 0.74 #  4.7 ± 0.96*#  8.7 ± 1*#  5.9± 0.62 # 5.5 ± 0.3*  
HFAT 5.4 ± 0.84 7.6 ± 1.03 # 5.3 ± 0.34*#  5.6 ± 0.8*#  5.7 ± 0.6 #  5.1± 0.42*  
Lactate  (mmol.L
-1
)       
HCHO 1.9 ± 0.42 7.8 ± 3.1 #  1.5 ± 0.3*#  1.6 ± 0.46 #  1.5 ± 0.16*# 1.1 ± 0.26 #  
HFAT 1.8 ± 0.41 7 ± 3.4 # 1.1 ± 0.22*#  1.3 ± 0.35 #  0.8 ± 0.21*#  0.9 ± 0.36 # 
NEFA 
(mmol.L
-1
) 
      
HCHO 0.01 ± 0.02 0.23 ± 0.27 #  0.09 ± 0.13 #  0.59 ± 0.56*#  0.09 ± 0.17*#  0.22 ± 0.22 #  
HFAT  0.05 ± 0.05  0.25 ± 0.28 #  0.32 ± 0.21 # 1.42 ± 0.74*#  0.48 ± 0.27*#  0.24 ± 0.14 # 
Glycerol 
 (μmol.L-1) 
      
HCHO 14.8 ± 6.07 92.8 ± 27.1 #  22.9 ± 12*#  50.2 ± 37.4*#  13.2 ± 4.39*#  23.4 ± 20.1 #  
HFAT  12.9 ± 4.82 79.3 ± 25.4 # 33 ± 7.3*#  122.9 ± 57*# 40.8 ± 12*#  30.85 ± 12.6# 
β-OHB  
(mmol.L
-1
) 
      
HCHO 0.07 ± 0.02 0.14 ± 0.04 # 0.07 ± 0.02*# 0.15 ± 0.08*# 0.08 ± 0.02*# 0.08 ± 0.03 
HFAT 0.07 ± 0.02  0.14 ± 0.04 #  0.11 ± 0.05*# 0.33 ± 0.21*# 0.29 ± 0.2*# 0.19 ± 0.017  
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